NVRO NYSE
Nevro Corp.
1W: -0.2%
1M: +1.9%
3M: +57.0%
1Y: -56.2%
3Y: -91.3%
5Y: -93.5%
$5.84
Last traded 2025-04-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$224.1M
52W Range3.165-13.3
Volume751,504
Avg Volume1,299,962
Beta0.82
Dividend—
Analyst Ratings
Company Info
CEOKevin R. Thornal
Employees1,099
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-11-06
Websitenevro.com
1800 Bridge Parkway
Redwood City, CA 94065
US
Redwood City, CA 94065
US
650 251 0005
About Nevro Corp.
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| GROSSMAN D KEITH | D-Return | 228,552 | $5.85 | 2025-04-03 |
| Kosaraju Sridhar | D-Return | 46,575 | $5.85 | 2025-04-03 |
| mcCormick Shawn | D-Return | 46,035 | $5.85 | 2025-04-03 |
| SIEGEL SUSAN E | D-Return | 7,382 | $5.85 | 2025-04-03 |
| Karros Kirt P | D-Return | 17,452 | $5.85 | 2025-04-03 |